A carregar...
Current and Emerging Targets in Immunotherapy for Osteosarcoma
Osteosarcoma is the most common primary malignancy of bone. Although outcomes of patients with osteosarcoma have improved since the introduction of chemotherapy, outcomes of metastatic or unresectable osteosarcomas are still unsatisfactory. To improve osteosarcoma outcomes, the development of novel...
Na minha lista:
| Publicado no: | J Oncol |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Hindawi
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6332920/ https://ncbi.nlm.nih.gov/pubmed/30693030 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2019/7035045 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|